NCT06470451Phase 3Terminated

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

Study sponsor: Soligenix

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-05-22Actual
Enrollment · participants70Actual
Source updated2026-07-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 80 participants (planned). After: 70 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Jul 2026. After: 22 May 2026.

Recruitment status changed

Before: Recruiting. After: Terminated.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview